Veristat Reduces Study Build Time from Weeks to Days with IBM Clinical Development

Study start-up and post-go-live protocol amendments can be lengthy, costly, and disruptive to a clinical trial. But with the right technology, data managers can accelerate timelines and overcome these challenges.

Join IBM Watson Health and Veristat to learn how Veristat was able to start up their COVID-19 trial in just 5 days and post-go-live protocol amendments in just 3 days. The discussion will focus on specific IBM Clinical Development features that Veristat used to achieve these results, and the positive impact that benefits the Sponsor of the study.

Tags

Veristat Reduces Study Build Time from Weeks to Days with IBM Clinical Development

Related Media